AT278241B - Verfahren zur Herstellung neuer Mono- und Bisacylderivate des Erythromycinoxims - Google Patents

Verfahren zur Herstellung neuer Mono- und Bisacylderivate des Erythromycinoxims

Info

Publication number
AT278241B
AT278241B AT668968A AT668968A AT278241B AT 278241 B AT278241 B AT 278241B AT 668968 A AT668968 A AT 668968A AT 668968 A AT668968 A AT 668968A AT 278241 B AT278241 B AT 278241B
Authority
AT
Austria
Prior art keywords
bisacyl
derivatives
preparation
erythromycin oxime
new mono
Prior art date
Application number
AT668968A
Other languages
English (en)
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Application granted granted Critical
Publication of AT278241B publication Critical patent/AT278241B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT668968A 1967-08-03 1968-07-11 Verfahren zur Herstellung neuer Mono- und Bisacylderivate des Erythromycinoxims AT278241B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU1540/67A YU31319B (en) 1967-08-03 1967-08-03 Postupak za dobijanje acil derivata eritromicin oksima

Publications (1)

Publication Number Publication Date
AT278241B true AT278241B (de) 1970-01-26

Family

ID=25554577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT668968A AT278241B (de) 1967-08-03 1968-07-11 Verfahren zur Herstellung neuer Mono- und Bisacylderivate des Erythromycinoxims

Country Status (7)

Country Link
US (1) US3574185A (de)
AT (1) AT278241B (de)
CH (1) CH503016A (de)
CS (1) CS151478B2 (de)
FR (1) FR1584610A (de)
SU (1) SU664568A3 (de)
YU (1) YU31319B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681326A (en) * 1971-01-11 1972-08-01 Abbott Lab 9-substituted erythromycin a and b oximes
US3869444A (en) * 1972-10-10 1975-03-04 Abbott Lab Esters of erythromycin oxime
US3855203A (en) * 1973-05-03 1974-12-17 Abbott Lab 4{41 -o-sulfonyl erythromycin-9-o-oxime derivatives
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics

Also Published As

Publication number Publication date
YU31319B (en) 1973-04-30
US3574185A (en) 1971-04-06
CH503016A (de) 1971-02-15
FR1584610A (de) 1969-12-26
CS151478B2 (de) 1973-10-19
SU664568A3 (ru) 1979-05-25

Similar Documents

Publication Publication Date Title
CH542853A (de) Verfahren zur Herstellung neuer Isothiocyano-benzazol-Derivate
AT289760B (de) Verfahren zur Herstellung neuer Oximäther und ihrer Salze
AT307628B (de) Verfahren zur Herstellung neuer heterocylischer Verbindungen
CH483400A (de) Verfahren zur Herstellung antistatisch wirksamer Verbindungen
AT278241B (de) Verfahren zur Herstellung neuer Mono- und Bisacylderivate des Erythromycinoxims
AT294854B (de) Verfahren zur Herstellung neuer D-Glucofuranoside
AT278242B (de) Verfahren zur Herstellung neuer Mono- und Bisacylderivate des Erythromycylamins
CH514673A (de) Verfahren zur Herstellung des Antibiotikums A 10 338
AT278822B (de) Verfahren zur Herstellung neuer Pyrimidinderivate
CH500215A (de) Verfahren zur Herstellung neuer Benzothiopyranopyridinderivate
CH515991A (de) Verfahren zur Herstellung des Antibiotikums Tsushimycin
AT282078B (de) Verfahren zur Herstellung neuer Nebularin-Derivate
AT283340B (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen und ihrer Salze
CH532562A (de) Verfahren zur Herstellung neuer 3-Oxo-A-nor-B-homo-pregnatriene
AT262505B (de) Verfahren zur Herstellung neuer Rifamycin SV-Derivate
CH462834A (de) Verfahren zur Herstellung neuer 6-Hydrazino-pyridazin-Derivate
CH491101A (de) Verfahren zur Herstellung neuer 3-Oxo-A,19-bis-nor-B-homo-steroid-4(10)-ene
AT283611B (de) Verfahren zur Herstellung neuer 3-Oxogonatrienderivate
AT297222B (de) Verfahren zur Herstellung neuer Rifamycin-Derivate
CH471828A (de) Verfahren zur Herstellung neuer 1,2a-Methylen-5a-androstanderivate
CH541558A (de) Verfahren zur Herstellung neuer Piperidon-Derivate
AT286511B (de) Verfahren zur Herstellung neuer 4-Imino-19-nor-A-homo-steroid-triene
CH473119A (de) Verfahren zur Herstellung neuer heterocyclischer Biguanid-Derivate
CH503031A (de) Verfahren zur Herstellung heterocyclischer Verbindungen
CH504529A (de) Verfahren zur Herstellung des Antibiotikums B-2847

Legal Events

Date Code Title Description
A1Z Withdrawn
ELJ Ceased due to non-payment of the annual fee